Paul King Deranian, MD
NPI 1154381374ActiveIndividual· Internal Medicine, Pulmonary Disease· Exeter, NH
Internal Medicine, Pulmonary Disease (MD) in Exeter, New Hampshire, licensed in NH, with an NPI issued in March 2006. Their prescriptions cost Medicare Part D more than their services did: $200,437 for 497 claims, against $32,350 paid for services in 2024. Glaxosmithkline, LLC. was the largest of 2 companies reporting payments in 2025, $294.25 in all, mostly food and beverage.
Overview
| NPI | 1154381374 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Mar 23, 2006 |
| Last updated in NPPES | Feb 24, 2020 |
| Certified by provider | Feb 24, 2020 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Pulmonary Disease Primary | 207RP1001X | 9477 | NH |
| Internal Medicine, Critical Care Medicine | 207RC0200X | 9477 | NH |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Pulmonary Disease (NH) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 171 |
|---|---|
| Services billed | 413 across 28 procedure codes |
| Paid by Medicare | $32,350 |
Part D prescriptions in 2024
| Prescriptions (claims) | 497 · 744 30-day fills |
|---|---|
| Patients | 83 |
| Total drug cost | $200,437 |
| Generic share | 33% of claims |
Industry payments (Open Payments)
- 2025$294.25 · 8 payments from 2 companies
- 2024$97.30 · 1 payment from 1 company
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Glaxosmithkline, LLC. | $201.09 | 7 |
| Merck Sharp & Dohme LLC | $93.16 | 1 |
What the 2025 payments were for
- Food and Beverage$294.25 · 8 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Pulmonary Disease providers in Exeter
- 1851339071
- 1194751743
All Internal Medicine, Pulmonary Disease providers in New Hampshire →